Search results for "nations"

showing 10 items of 483 documents

Mechanistic Explanations and Deliberate Misrepresentations

2020

The philosophy of mechanisms has developed rapidly during the last 30 years. As mechanisms-based explanations (MBEs) are often seen as an alternative to nomological, law-based explanations, MBEs could be relevant in IS. We begin by offering a short history of mechanistic philosophy and set out to clarify the contemporary landscape. We then suggest that mechanistic models provide an alternative to variance and process models in IS. Finally, we highlight how MBEs typically contain deliberate misrepresentations. Although MBEs have recently been advocated as critical realist (CR) accounts in IS, idealizations (deliberate misrepresentations) seem to violate some fundamental tenets of CR and rese…

Philosophy of sciencemechanisms-based explanationsselittäminenmekanismitPsychologyNaturalismEpistemologyProceedings of the Annual Hawaii International Conference on System Sciences
researchProduct

Challenging the negative images of Haiti at a pre-visit stage using visual online learning materials

2016

Post-conflict destinations can struggle to attract visitors because of their negative image. Research addressing this remains limited. The same can be said about the education of tourists. This research paper contributes to the literature in both areas as it examines the proposition that the education of tourists at a pre-visit stage using online, game-based material could be effective in challenging the negative perception of these destinations. From a destination management point of view, this paper offers an alternative to existing promotional material as there is little evidence at the moment that existing strategies are effective. From a conceptual point of view, this paper contributes…

Point (typography)business.industryComputer scienceOnline learning05 social sciencesGeography Planning and DevelopmentPropositionDestination managementDestinationsPublic relationsMarketing strategyTourism Leisure and Hospitality Management0502 economics and business050211 marketingThe InternetMarketingNegative perceptionbusiness050212 sport leisure & tourismJournal of Policy Research in Tourism, Leisure and Events
researchProduct

Tourism planning and innovation: The Caribbean under the spotlight

2018

International audience; The importance of the islands working together toward a multicentre product for tourists has been highlighted asearly as the 1980s, and yet hardly anything has been done in that sense. Can cluster be considered as the wayforward for the sustainable development of the Caribbean? This question could be considered as the first step ofthe tourism planning process. Hierarchical method or linkage method that works by identifying entities thatmatch each other based on the investigator selection of similar attribute categories is the most suitable clusteringapproach for the Caribbean. Despite the fact that cluster appears as a potential solution for issues faced by someCarib…

Process (engineering)Strategy and ManagementLinkage (mechanical)DestinationsTourism[SHS]Humanities and Social Scienceslaw.inventionPanacea (medicine)law11. Sustainability0502 economics and businessRegional scienceBusiness and International ManagementCaribbeanMarketingSustainable developmentCaribbean island05 social sciencesProduct (business)ClusterTourism Leisure and Hospitality Management[SHS.GESTION]Humanities and Social Sciences/Business administration050211 marketingBusiness050212 sport leisure & tourismTourismTourism planningJournal of Destination Marketing & Management
researchProduct

A replication study of JTC bias, genetic liability for psychosis and delusional ideation

2022

The EUGEI project was supported by the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O'Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/L010305/1)

PsychosisfamilyHallucinationsCONVICTIONDecision Makingneuropsychology03 medical and health sciences0302 clinical medicineCognitionBiasmedicineHumansSpectrum disorderpsychosisSiblingVALIDITYAssociation (psychology)jumping to conclusionsApplied PsychologyNeuropsychologyCognitionmedicine.disease030227 psychiatryPsychiatry and Mental healthCONTINUUMPsychotic DisordersRelative riskJumping to conclusionsCONCLUSIONSRELIABILITYSchizophreniadelusionsreasoningPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Auditory hallucinations in anorexia nervosa

2011

The paper describes two case studies of patients with anorexia nervosa who suffer from auditory hallucinations as the only psychotic symptom. A review of the literature regarding clinical cases of anorexic patients with hallucinations is discussed. Hallucinations in anorexic patients are conceptualized according to different theoretical models which point to a dimensional view of eating disorders. Copyright © 2011 John Wiley & Sons, Ltd and Eating Disorders Association.

Psychosismedicine.medical_specialtyAnorexia NervosaAdolescentHallucinationsdigestive oral and skin physiologyTheoretical modelsmedicine.diseaseDiagnosis DifferentialPsychiatry and Mental healthClinical PsychologyEating disordersAnorexia nervosa (differential diagnoses)medicineHumansFemalePsychologyPsychiatryAssociation (psychology)Clinical psychologyEuropean Eating Disorders Review
researchProduct

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.

2011

SummaryRecommended treatment for moderate to severe asthma is the combination of an inhaled corticosteroid and a long-acting beta2-agonist. The present study was designed to evaluate the efficacy of a newly developed fixed combination of ciclesonide and formoterol in comparison to the marketed fixed combination of fluticasone and salmeterol in patients with moderate asthma.This was a phase II, multi-centre, randomized, parallel-group, double-blind, double-dummy study. After a 2-week run-in period, 160 patients with moderate asthma were randomized to a 6-week treatment with ciclesonide/formoterol 320/9 μg bid (CIC/F) or fluticasone propionate/salmeterol 250/50 μg bid (FP/S), both delivered a…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUrologyCiclesonideCiclesonideFluticasone propionatechemistry.chemical_compoundYoung AdultDouble-Blind Methodimmune system diseasesPregnenedionesForced Expiratory VolumeFormoterol FumarateGermanyAdministration InhalationmedicineHumansFixed combinationAlbuterolFormoterolAnti-Asthmatic AgentsChildGlucocorticoidsFluticasoneAgedFluticasone-Salmeterol Drug Combinationbusiness.industryrespiratory systemMiddle AgedAsthmaFluticasone-Salmeterol Drug Combinationrespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilitychemistryEthanolaminesAustriaFormoterol FumarateFemaleSalmeterolFormoterolbusinessmedicine.drugRespiratory medicine
researchProduct

Revising old principles of inhaled treatment in new fixed combinations for asthma.

2015

The major influencing factors on persistent asthma control are the selected treatment(s), the drug delivery route and patient's adherence to therapy, together with the influence of lifestyle (i.e. sedentary habit), comorbid conditions and specific asthma phenotypes. Inhaled corticosteroids (ICS) in combination with a long-acting β2-agonist (LABA) are the gold standard for management of persistent asthma, with maximal local targeting and minimal systemic side effects. Several innovative inhaler devices have been developed for effective local drug administration and good patient compliance to therapy. Recently, a new ICS/LABA fixed combination, formulated with fluticasone propionate (FP) and …

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtyDoseAdolescentmedicine.drug_classSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionateFluticasone propionatelaw.inventionMedication AdherenceRandomized controlled triallawInternal medicineDrug CombinationFormoterol FumarateAdministration InhalationmedicineCorticosteroidAnti-Asthmatic AgentHumansPharmacology (medical)Anti-Asthmatic AgentsBronchodilator AgentAsthmabusiness.industryInhalerMedicine (all)Biochemistry (medical)medicine.diseaseAsthmaDiscontinuationInhaled treatmentBronchodilator AgentsDrug CombinationsAnesthesiaCorticosteroidFluticasoneFormoterol Fumaratebusinessmedicine.drugHumanPulmonary pharmacologytherapeutics
researchProduct

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial …

2012

The inhaled corticosteroid fluticasone propionate (fluticasone) and the long-acting β₂ agonist formoterol fumarate (formoterol) have been combined in a single aerosol inhaler fluticasone/formoterol (flutiform(®)). This study compared the efficacy and safety of fluticasone/formoterol with the combination product budesonide/formoterol (Symbicort(®) Turbohaler(®)).A randomized, double-blind, double-dummy, multicenter, Phase 3 study comprising a 7- (± 3) day screening, 2-4-week run-in, and 12-week treatment periods. Patients aged ≥ 12 years with moderate to severe persistent asthma for ≥ 6 months before screening and forced expiratory volume in one second (FEV₁) 50-80% predicted and ≥ 15% rever…

Pulmonary and Respiratory MedicineBudesonideAdultMaleAdolescentFluticasone propionateYoung AdultDouble-Blind Methodimmune system diseasesForced Expiratory VolumeFormoterol FumarateAdministration InhalationImmunology and AllergyMedicineHumansBudesonideFluticasoneAgedbusiness.industryInhalerDry Powder Inhalersrespiratory systemMiddle AgedAsthmarespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsBudesonide/formoterolEthanolaminesAnesthesiaPediatrics Perinatology and Child HealthSalbutamolFluticasoneFormoterol FumarateFemaleFormoterolbusinesshormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

2011

Objective: Baseline inhaled corticosteroid (ICS) dose may be a factor for prescribers to consider when they select a budesonide/formoterol maintenance and reliever therapy regimen for symptomatic asthmatics. Methods: A 6-month randomized study compared two maintenance doses of budesonide/formoterol 160/4.5 µg, 1 × 2 and 2 × 2, plus as needed, in 8424 asthma patients with symptoms when treated with ICS ± an inhaled long-acting β2-agonist (LABA). In the total study population, 1339 (17%) were high-dose ICS (HD) users (≥1600 µg/day budesonide). This HD stratum was compared with the rest of the study population, divided into low-dose (LD; 400 µg/day) and medium-dose strata (MD; 401–1599 µg/day…

Pulmonary and Respiratory MedicineBudesonideAdultMalemedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classSeverity of Illness Indexlaw.inventionYoung AdultRandomized controlled triallawAdrenal Cortex HormonesInternal medicineSurveys and QuestionnairesAdministration InhalationmedicineBudesonide Formoterol Fumarate Drug CombinationHumansPharmacology (medical)Anti-Asthmatic AgentsBudesonideAsthmaAgedlcsh:RC705-779Aged 80 and overDose-Response Relationship Drugbusiness.industrylcsh:Diseases of the respiratory systemMiddle Agedmedicine.diseaseAsthmaRegimenDrug CombinationsTreatment OutcomeBudesonide/formoterolAsthma Control QuestionnaireEthanolaminesAnesthesiaCorticosteroidFemaleFormoterolbusinessmedicine.drugTherapeutic advances in respiratory disease
researchProduct

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever u…

2012

Abstract Background Divergent strategies have emerged for the management of severe asthma. One strategy utilises high and fixed doses of maintenance treatment, usually inhaled corticosteroid/long-acting β2-agonist (ICS/LABA), supplemented by a short-acting β2-agonist (SABA) as needed. Alternatively, budesonide/formoterol is used as both maintenance and reliever therapy. The latter is superior to fixed-dose treatment in reducing severe exacerbations while achieving similar or better asthma control in other regards. Exacerbations may be reduced by the use of budesonide/formoterol as reliever medication during periods of unstable asthma. We examined the risk of a severe exacerbation in the per…

Pulmonary and Respiratory MedicineBudesonideExacerbationAsthma in primary careSeverity of Illness Indexlaw.inventionRandomized controlled trialDouble-Blind MethodlawAdrenal Cortex HormonesRisk FactorsFormoterol FumarateAdministration InhalationmedicineBudesonide Formoterol Fumarate Drug CombinationHumansAnti-Asthmatic AgentsBudesonideAsthmalcsh:RC705-779Maintenance dosebusiness.industryResearchlcsh:Diseases of the respiratory systemmedicine.diseaseAsthmaBronchodilator AgentsDrug CombinationsTreatment OutcomeBudesonide/formoterolEthanolaminesAnesthesiaDisease ProgressionFormoterol FumarateDrug Therapy CombinationFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugRespiratory research
researchProduct